{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:20:07Z","timestamp":1772785207650,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T00:00:00Z","timestamp":1655596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cellsig.2022.110386","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T11:46:55Z","timestamp":1655120815000},"page":"110386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Glutamatergic transmission and receptor expression in the synucleinopathy h-\u03b1-synL62 mouse model: Effects of hydromethylthionine"],"prefix":"10.1016","volume":"97","author":[{"given":"Karima","family":"Schwab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoi","family":"Chasapopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Frahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy","family":"Magbagbeolu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Cranston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles R.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude M.","family":"Wischik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Theuring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2022.110386_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cellsig.2022.110386_bb0010","article-title":"Pathophysiology of motor dysfunction in Parkinson\u2019s disease as the rationale for drug treatment and rehabilitation","volume":"2016","author":"Magrinelli","year":"2016","journal-title":"Parkinsons. Dis."},{"key":"10.1016\/j.cellsig.2022.110386_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.parkreldis.2007.06.007","article-title":"The premotor phase of Parkinson\u2019s disease","volume":"13","author":"Tolosa","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.cellsig.2022.110386_bb0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/mdc3.13122","article-title":"Prevalence of non-motor symptoms and non-motor fluctuations in Parkinson\u2019s disease using the MDS-NMS","volume":"8","author":"Rodriguez-Blazquez","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.cellsig.2022.110386_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.00028","article-title":"\u0391-Synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling","volume":"13","author":"Huang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tcb.2017.02.002","article-title":"\u03b1-Synuclein \u2013 regulator of exocytosis, endocytosis, or both?","volume":"27","author":"Lautenschl\u00e4ger","year":"2017","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cellsig.2022.110386_bb0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron."},{"key":"10.1016\/j.cellsig.2022.110386_bb0040","doi-asserted-by":"crossref","first-page":"11750","DOI":"10.1523\/JNEUROSCI.0234-12.2012","article-title":"Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation","volume":"32","author":"Di\u00f3genes","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0045","first-page":"879","article-title":"Aggregation of \u03b1-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellsig.2022.110386_bb0050","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"a -Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110386_bb0055","first-page":"151","article-title":"Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia","volume":"55","author":"Trojanowski","year":"1998","journal-title":"Neurol. Rev."},{"key":"10.1016\/j.cellsig.2022.110386_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00295","article-title":"Alpha-synuclein: from early synaptic dysfunction to neurodegeneration","volume":"9","author":"Ghiglieri","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cellsig.2022.110386_bb0065","article-title":"Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease","volume":"2","author":"Perez-Lloret","year":"2016","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.cellsig.2022.110386_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-Synuclein induced synaptopathy in parkinson\u2019s disease","volume":"12","author":"Bridi","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuroscience.2019.12.002","article-title":"Modified glutamatergic postsynapse in neurodegenerative disorders","volume":"454","author":"Moraes","year":"2021","journal-title":"Neuroscience."},{"key":"10.1016\/j.cellsig.2022.110386_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","article-title":"Glutamate receptor function in learning and memory","volume":"140","author":"Riedel","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cellsig.2022.110386_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mcn.2018.05.002","article-title":"Functional organization of postsynaptic glutamate receptors","volume":"91","author":"Scheefhals","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuron.2013.09.045","article-title":"Kainate receptors in health and disease","volume":"80","author":"Lerma","year":"2013","journal-title":"Neuron."},{"key":"10.1016\/j.cellsig.2022.110386_bb0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cellsig.2022.110386_bb0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0896-6273(04)00265-X","article-title":"Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals","volume":"42","author":"Bamford","year":"2004","journal-title":"Neuron."},{"key":"10.1016\/j.cellsig.2022.110386_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2020.585584","article-title":"Molecular mechanisms of glutamate toxicity in Parkinson\u2019s disease","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1750-3639.2004.tb00082.x","article-title":"Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse lewy body disease is associated with irregular \u03b1-synuclein\/phospholipase C (PLC\u03b21) interactions","volume":"14","author":"Dalf\u00f3","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.cellsig.2022.110386_bb0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.nbd.2005.05.001","article-title":"Impaired metabotropic glutamate receptor\/phospholipase C signaling pathway in the cerebral cortex in Alzheimer\u2019s disease and dementia with Lewy bodies correlates with stage of Alzheimer\u2019s-disease-related changes","volume":"20","author":"Albasanz","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cellsig.2022.110386_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0334-3","article-title":"Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations","volume":"4","author":"Khundakar","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.cellsig.2022.110386_bb0125","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing \u03b1-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cellsig.2022.110386_bb0130","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.0066-08.2008","article-title":"\u03b1-Synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice","volume":"28","author":"Crews","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0135","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in \u03b1-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science (80-)."},{"key":"10.1016\/j.cellsig.2022.110386_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024834","article-title":"Neuropathology in mice expressing mouse alpha-synuclein","volume":"6","author":"Rieker","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2022.110386_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-14-6","article-title":"Time course and progression of wild type \u03b1-Synuclein accumulation in a transgenic mouse model","volume":"14","author":"Amschl","year":"2013","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbr.2017.11.025","article-title":"Alpha-Synuclein transgenic mice, h-\u03b1-SynL62, display \u03b1-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson\u2019s disease","volume":"339","author":"Frahm","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cellsig.2022.110386_bb0155","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1021\/acschemneuro.8b00274","article-title":"Increased cholinergic response in \u03b1-synuclein transgenic mice (h-\u03b1-synL62)","volume":"10","author":"K\u00f6nig","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0160","first-page":"1","article-title":"The arrive guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.cellsig.2022.110386_bb0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0960-894X(02)00997-6","article-title":"[3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor","volume":"13","author":"Cosford","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cellsig.2022.110386_bb0170","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/jpet.105.090449","article-title":"The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol- 4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems","volume":"315","author":"Cowen","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellsig.2022.110386_bb0175","first-page":"316","article-title":"Stability of memantine in an extemporaneously prepared oral liquid","volume":"4","author":"Yamreudeewong","year":"2006","journal-title":"Int. J. Pharm. Compd."},{"key":"10.1016\/j.cellsig.2022.110386_bb0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jnr.22172","article-title":"Memantine lowers amyloid-\u03b2 peptide levels in neuronal cultures and in APP\/PS1 transgenic mice","volume":"88","author":"Alley","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cellsig.2022.110386_bb0185","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/npp.2008.53","article-title":"Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"33","author":"Dong","year":"2008","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.cellsig.2022.110386_bb0190","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbr.2010.03.036","article-title":"Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome","volume":"221","author":"Lockrow","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cellsig.2022.110386_bb0195","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.104.071027","article-title":"Memantine improves spatial learning in a transgenic mouse model of Alzheimer\u2019s disease","volume":"311","author":"Minkeviciene","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellsig.2022.110386_bb0200","series-title":"The Mouse Brain in Stereotaxic Coordinates, Compact","author":"Paxinos","year":"2019"},{"key":"10.1016\/j.cellsig.2022.110386_bb0205","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12035-015-9674-4","article-title":"Endogenous apolipoprotein E (ApoE) fragmentation is linked to amyloid pathology in transgenic mouse models of Alzheimer\u2019s disease","volume":"54","author":"Saul","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cellsig.2022.110386_bb0210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00401-009-0539-7","article-title":"APP\/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy","volume":"117","author":"Breyhan","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cellsig.2022.110386_bb0215","doi-asserted-by":"crossref","first-page":"E4736","DOI":"10.1073\/pnas.1609702113","article-title":"PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP61","volume":"113","author":"Won","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2022.110386_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2017.00447","article-title":"A protein aggregation inhibitor, leuco-methylthioninium bis(Hydromethanesulfonate), decreases \u03b1-synuclein inclusions in a transgenic mouse model of synucleinopathy","volume":"10","author":"Schwab","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0225","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/brain\/awq132","article-title":"SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson\u2019s disease","volume":"133","author":"Garcia-Reitb\u00f6ck","year":"2010","journal-title":"Brain."},{"key":"10.1016\/j.cellsig.2022.110386_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105185","article-title":"Oligomeric \u03b1-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson\u2019s disease","volume":"148","author":"Agliardi","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cellsig.2022.110386_bb0235","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1074\/mcp.RA118.001290","article-title":"Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer\u2019s disease cerebrospinal fluid*","volume":"18","author":"Lle\u00f3","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cellsig.2022.110386_bb0240","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)64573-7","article-title":"Staging of cytoskeletal and \u03b2-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer\u2019s disease","volume":"157","author":"Mukaetova-Ladinska","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellsig.2022.110386_bb0245","first-page":"1","article-title":"Roles of glutamate receptors in Parkinson\u2019s disease","volume":"20","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0250","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/jnc.13713","article-title":"Synaptopathies: synaptic dysfunction in neurological disorders \u2013 a review from students to students","author":"Lepeta","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cellsig.2022.110386_bb0255","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1523\/JNEUROSCI.0527-20.2020","article-title":"NMDA receptor enhances correlation of spontaneous activity in neonatal barrel cortex","volume":"41","author":"Mizuno","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cellsig.2022.110386_bb0260","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s11064-019-02733-4","article-title":"Expression changes of NMDA and AMPA receptor subunits in the hippocampus in rats with diabetes induced by Streptozotocin coupled with memory impairment","volume":"44","author":"Wang","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cellsig.2022.110386_bb0265","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbr.2012.02.014","article-title":"Reducing expression of GluN1 0XX subunit splice variants of the NMDA receptor interferes with spatial reference memory","volume":"230","author":"Das","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cellsig.2022.110386_bb0270","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainresbull.2020.12.017","article-title":"Research on developing drugs for Parkinson\u2019s disease","volume":"168","author":"Zhang","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.cellsig.2022.110386_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113810","article-title":"Memantine exerts neuroprotective effects by modulating \u03b1-synuclein transmission in a parkinsonian model","volume":"344","author":"Lee","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cellsig.2022.110386_bb0280","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre","year":"2010","journal-title":"Lancet Neurol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656822001486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656822001486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:07:18Z","timestamp":1760267238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656822001486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":56,"alternative-id":["S0898656822001486"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2022.110386","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamatergic transmission and receptor expression in the synucleinopathy h-\u03b1-synL62 mouse model: Effects of hydromethylthionine","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2022.110386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110386"}}